|
Methods and compositions for treating ataxia telangiectasia
Methods and compositions for treating ataxia telangiectasia
Background
Ataxia telangiectasia (A-T) is an incurable autosomal recessive disease that occurs in 1 in 40,000 to 100,000 people worldwide. It is caused by mutations in the Ataxia Telangiectasia Mutated (ATM) gene. A-T is characterized by neurodegeneration in the central nervous system, immune...
Published: 6/26/2025
|
Updated: 5/30/2023
|
Inventor(s): Timothy Yu, Jinkuk Kim
Keywords(s): CNS, Gene Therapy, Genetic Disorder, Rare Disease
Category(s): Technology Classifications > Invention Type, Technology Classifications > Invention Type > Therapeutics, Technology Classifications > Invention Type > Therapeutics > ASOs, Technology Classifications > Disease Area, Technology Classifications > Disease Area > Rare Diseases, Technology Classifications > Disease Area > Neurology
|